Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG pasteur and M. bovis BCG Danish

Clinical and Vaccine Immunology

Volumn 18, Issue 3, 2011, Pages 373-379

  Hope, J C ^a   Thom, M L ^a   McAulay, M ^a   Mead, E ^a   Vordermeier, H M ^b   Clifford, D ^b   Hewinson, R G ^b   Villarreal Ramos, B ^a,b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BOVINE TUBERCULOSIS; CALF (BOVINE); CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; IMMUNE RESPONSE; INFECTION PREVENTION; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; MYCOBACTERIUM BOVIS; NEWBORN; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN TEST; STRAIN DIFFERENCE; VACCINATION;

ANIMALS; BACTERIAL LOAD; BCG VACCINE; BIOLOGICAL MARKERS; CATTLE; CELLS, CULTURED; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS, BOVINE;

EID: 79952567333     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00543-10     Document Type: Article

References (41)

1. Buddle, B. M. 2010. Tuberculosis vaccines for cattle: the way forward. Expert Rev. Vaccines 9:1121-1124.
2. Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130.
3. Buddle, B. M., et al. 2003. Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. Vet. Rec. 153:615-620.
4. Buddle, B. M., et al. 1999. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin. Diagn. Lab. Immunol. 6:1-5.
5. Buddle, B. M., T. J. Ryan, J. M. Pollock, P. Andersen, and G. W. de Lisle. 2001. Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing. Vet. Microbiol. 80:37-46.
6. Buddle, B. M., B. J. Wards, F. E. Aldwell, D. M. Collins, and G. W. de Lisle. 2002. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20:1126-1133. (Pubitemid 34135948)
7. Buddle, B. M., D. N. Wedlock, M. Denis, and M. A. Skinner. 2005. Identification of immune response correlates for protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 108:45-51.
8. Buddle, B. M., et al. 2003. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect. Immun. 71:6411-6419.
9. Calarota, S. A., et al. 2008. HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J. Immunol. 180:5907-5915.
10. Castillo-Rodal, A. I., et al. 2006. Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect. Immun. 74:1718-1724.
11. Cockle, P. J., et al. 2002. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70:6996-7003.
12. Endsley, J. J., et al. 2007. Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity. Vaccine 25:8384-8394. (Pubitemid 350137604)
13. Ferraz, J. C., et al. 2004. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice. Infect. Immun. 72:6945-6950.
14. Fine, P. E. 1995. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339-1345.
15. Gallagher, J., and D. M. Horwill. 1977. A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis. J. Hyg. (Lond.) 79:155-160.
16. Garnier, T., et al. 2003. The complete genome sequence of Mycobacterium bovis. Proc. Natl. Acad. Sci. U. S. A. 100:7877-7882.
17. Goletti, D., et al. 2006. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J. Infect. Dis. 194:984-992.
18. Hogarth, P. J., R. G. Hewinson, and H. M. Vordermeier. 2006. Development of vaccines against bovine tuberculosis. J. Pharm. Pharmacol. 58:749-757.
19. Hope, J. C., L. S. Kwong, P. Sopp, R. A. Collins, and C. J. Howard. 2000. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guerin vaccinated and nonvaccinated cattle. Scand. J. Immunol. 52:285-291.
20. Hope, J. C., et al. 2005. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis. Clin. Exp. Immunol. 139:48-56.
21. Hope, J. C., and B. Villarreal-Ramos. 2008. Bovine TB and the development of new vaccines. Comp. Immunol. Microbiol. Infect. Dis. 31:77-100.
22. Hope, J. C., and H. M. Vordermeier. 2005. Vaccines for bovine tuberculosis: current views and future prospects. Expert Rev. Vaccines 4:891-902.
23. Kwong, L. S., et al. 2002. Development of an ELISA for bovine IL-10. Vet. Immunol. Immunopathol. 85:213-223.
24. Marchant, A., et al. 1999. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J. Immunol. 163:2249-2255. (Pubitemid 29382234)
25. McShane, H., and A. Hill. 2005. Prime-boost immunisation strategies for tuberculosis. Microbes Infect. 7:962-967. (Pubitemid 40826666)
26. McShane, H., et al. 2005. Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials. Tuberculosis (Edinb.) 85:47-52. (Pubitemid 40431315)
27. Morrison, W. I., et al. 2000. Pathogenesis and diagnosis of infections with Mycobacterium bovis in cattle. Independent Scientific Group on Cattle TB. Vet. Rec. 146:236-242.
28. Palmer, M. V., T. C. Thacker, and W. R. Waters. 2009. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis. Zoonoses Public Health 56:243-251.
29. Sopp, P., C. J. Howard, and J. C. Hope. 2006. Flow cytometric detection of gamma interferon can effectively discriminate Mycobacterium bovis BCG-vaccinated cattle from M. bovis-infected cattle. Clin. Vaccine Immunol. 13:1343-1348.
30. Todryk, S. M., et al. 2009. The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. Immunology 128:83-91.
31. Vekemans, J., et al. 2001. Neonatal bacillus Calmette-Guerin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur. J. Immunol. 31:1531-1535.
32. Vordermeier, H. M., M. A. Chambers, B. M. Buddle, J. M. Pollock, and R. G. Hewinson. 2006. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. Vet. J. 171:229-244.
33. Vordermeier, H. M., et al. 2002. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 70:3026-3032.
34. Vordermeier, H. M., P. J. Cockle, A. O. Whelan, S. Rhodes, and R. G. Hewinson. 2000. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guerin vaccination in cattle. Clin. Infect. Dis. 30(Suppl. 3):S291-S298.
35. Vordermeier, H. M., et al. 2004. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112:461-470. (Pubitemid 38859525)
36. Vordermeier, H. M., et al. 2009. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 77:3364-3373.
37. Vordermeier, H. M., et al. 2001. Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle. Clin. Diagn. Lab. Immunol. 8:571-578.
38. Waters, W. R., et al. 2009. Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves. Vaccine 27:1201-1209.
39. Wedlock, D. N., M. Denis, H. M. Vordermeier, R. G. Hewinson, and B. M. Buddle. 2007. Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis. Vet. Immunol. Immunopathol. 118:50-58.
40. Whelan, A. O., et al. 2008. Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations. Vaccine 26:166-173. (Pubitemid 350266128)
41. Zhang, Y., et al. 2003. CpG ODN 2006 and IL-12 are comparable for priming Th1 lymphocyte and IgG responses in cattle immunized with a rickettsial outer membrane protein in alum. Vaccine 21:3307-3318. (Pubitemid 36700431)